Peptide-Based Drug Delivery Strategies Offer New Hope for Osteoarthritis Treatment
Recent advancements in peptide-based targeted drug delivery strategies are showing promise in the treatment of osteoarthritis (OA). Researchers are exploring the use of peptides to enhance drug delivery to specific tissues within the joint, such as cartilage, synovium, and subchondral bone. These peptides can be incorporated into various drug delivery systems, including nanoparticles and exosomes, to improve the targeting and retention of therapeutic agents. The approach aims to address the challenges of delivering drugs to the dense extracellular matrix of cartilage and the inflamed synovium, potentially improving treatment outcomes for OA patients. 
